Preliminary Agenda for Targeting Mitochondria 2018

  9th World Congress on

 Targeting Mitochondria


23-25 October 2018 - Berlin, Germany


 Preliminary Agenda


Speakers & topics already confirmed:

Mitochondrial Medicine: Recent Advances & Perspectives
Alessia Angelin, Children's Hospital of Philadelphia, Philadelphia, USA

The transcriptomic and proteomic landscape of mitochondrial dysfunction in mouse
Inge Kühl,
 CNRS - Institut de Biologie Intégrative de la cellule (I2BC), Gif-sur-Yvette, France

Role of mitochondrial potassium channels in cellular function during health and disease
Adam Szewczyk, Nencki Institute of Experimental Biology, Warsaw, Poland

Mechanism and therapeutic potential of cyclophilin inhibitors for prevention of mitochondrial myopathy progression
Håkan Westerblad, Karolinska Intitutet, Stockholm, Sweden

Phase 2 motor study of Omaveloxolone in patients with mitochondrial myopathies
John Vissing, Copenhagen University, Copenhagen, Denmark

The legal framework for mitochondrial therapy
Identifying and preventing legal pitfalls within the translation from bench to bedside
Timo Faltus, Martin-Luther-Universität Halle-Wittenberg, Halle, Germany

Utilizing a human hepatoma cell line to study off-target effects of drugs on mitochondrial DNA maintenance and bioenergetics
Matthew Young, Southern Illinois University School of Medicine, Carbondale, USA

Targeting mitochondrial metabolism, geroprotection to treating Alzheimer’s disease
Antonio Currais, The Salk Institute for Biological Studies, La Jolla, USA

The mitochondrial link to cocaine addiction: recent scientific advances
Mary Kay Lobo, University of Maryland School of Medicine, Baltimore, USA

Mitochondrial involvement in cell life/death regulation: Presentation of new scientific results
Vladimir Gogvadze, Korolinska Institute, Stockholm, Sweden

Metabolic switches saving mitochondria from oxidative stress
Carsten Culmsee, Universität Marburg, Marburg, Germany

Mitochondrial dynamics in cell life and death
Luca Scorrano, University of Padova, Padova, Italy

Cellomics of mitochondrial morphofunction
Werner Koopman, RadboudUMC University, Nijmegen, The Netherlands

Therapeutic application of specific near-infrared light wavelengths that inhibit cytochrome C oxidase results in robust neuroprotection.
Maik Hüttemann, Wayne State University School of Medicine, Detroit, USA



Day 1 


07:45 Registration & Welcoming of attendees

09:00 Opening Ceremony by Targeting Mitochondria World Congress Chairmen

Session 1: Recent Advances on Mitochondrial Dysfunctions in Chronic Diseases: The Mechanistics


  • Mitochondria & Redox Regulation
  • Mitochondria & Viral Infection
  • Mitochondria & Metabolic Syndrome
  • Mitochondria & Neurodegenerative Diseases
  • Mitochondria & Cancer 


Session 2: Mitochondria Dynamics in Health & Diseases




Session 3: The challenge of qualitative and quantitative assessment of mitochondrial function in vitro and in vivo 

  • Mitochondria Quality Control
  • Mitochondria Devices: New methods to detect mitochondria dysfunction
  • Mitochondria as Biomarkers
  • Presentation of Practical Cases  

18:30 End of the first day

20:00 Targeting Mitochondria Dinner  


Day 2    

08:55 Opening of the second day

Session 4 Mitochondria & Microbiota Intertalk



Session 5: Strategies to target mitochondria:
Clinical trials and potential mitochondria-based therapies

  • Strategies to target stem cells
  • Strategies to reimplace mitochondria
  • Strategies to target miRNA

  • Strategies to reimplace mitochondria
  • Clinical & Therapeutic Directions  


18:00 Conclusion of Targeting Mitochondria 2018

18:15 Targeting Mitochondria 2018 Awards

18:30 End of Targeting Mitochondria 2018